Idt Australia Ltd (ASX:IDT) Share Price & Analysis

IDT Australia Limited (ASX: IDT) is a long-established, specialized pharmaceutical manufacturing company headquartered in Boronia, Victoria, that provides comprehensive contract development and manufacturing organization (CDMO) services to global healthcare markets through its state-of-the-art TGA and FDA-registered facilities. The company’s integrated business model encompasses the entire drug development lifecycle, ranging from initial research and analytical chemistry to the large-scale commercial production of high-potency active pharmaceutical ingredients (APIs) and complex finished dose forms in both oral and injectable formats. Beyond traditional pharmaceutical production, IDT Australia has established a significant presence in the emerging medicinal cannabis and psychedelics sectors, offering specialized extraction, formulation, and clinical packaging services for various cannabinoid-based medicines and other niche therapeutic products requiring high-containment manufacturing environments. The entity’s technical capabilities include rigorous microbiological and analytical testing, stability monitoring, and comprehensive regulatory affairs support, ensuring that all manufactured products meet the stringent international quality standards required for distribution across Australia, Asia, Europe, and the United States. By leveraging its unique high-containment infrastructure and deep technical expertise, the company supports a diverse range of global pharmaceutical partners and plays a critical role in Australia’s sovereign manufacturing capability for high-value specialty drugs, including advanced mRNA therapeutics and antibody-drug conjugates.